Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.3
edited by Sarantis Dimitriadis
on 2022/06/02 09:58
Change comment: There is no comment for this version
To version 5.11
edited by Sarantis Dimitriadis
on 2022/06/07 10:26
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,6 +7,8 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 +:
11 +
10 10  * (((
11 11  (% lang="en-US" %)**Non-professional end users:**
12 12  
... ... @@ -15,6 +15,8 @@
15 15  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 16  )))
17 17  
20 +:
21 +
18 18  * (((
19 19  (% lang="en-US" %)**Professional end users**
20 20  
... ... @@ -25,9 +25,13 @@
25 25  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 26  )))
27 27  
32 +:
33 +
28 28  (% class="western" lang="en-GB" %)
29 29  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 30  
37 +:
38 +
31 31  * (((
32 32  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 33  
... ... @@ -42,6 +42,8 @@
42 42  * (% lang="en-US" %)Pharmaceutical companies
43 43  )))
44 44  
53 +:
54 +
45 45  * (((
46 46  (% lang="en-GB" %)
47 47  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -57,6 +57,8 @@
57 57  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 58  )))
59 59  
70 +:
71 +
60 60  * (((
61 61  (% lang="en-GB" %)
62 62  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -70,6 +70,8 @@
70 70  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 71  )))
72 72  
85 +:
86 +
73 73  * (((
74 74  (% lang="en-GB" %)
75 75  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -77,6 +77,8 @@
77 77  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 78  )))
79 79  
94 +:
95 +
80 80  * (((
81 81  (% lang="en-GB" %)
82 82  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -85,276 +85,240 @@
85 85  * (% lang="en-US" %)International, national, regional and local networks
86 86  )))
87 87  
104 +:
105 +
88 88  (% class="western" lang="en-GB" %)
89 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
107 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
90 90  
91 -
92 -(% cellspacing="0" class="table-hover" style="margin-left:auto; margin-right:auto" %)
93 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)(((
109 +(% style="margin-left:auto; margin-right:auto" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)(((
94 94  (% class="western" lang="en-GB" style="text-align:center" %)
95 -(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group**
112 +(% lang="en-US" %)**Age or age group**
96 96  )))
97 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
98 -(% class="western" lang="en-GB" %)
99 -(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range
100 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
101 -(% class="western" %)
114 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
115 +(% lang="en-US" %)Specific age range
116 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
102 102  
103 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
104 104  (% class="western" %)
105 105  
106 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
121 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
107 107  (% class="western" %)
108 108  
109 109  )))
110 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
125 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
111 111  (% class="western" lang="en-GB" %)
112 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly
113 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
127 +(% lang="en-US" %)Elderly
128 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
114 114  (% class="western" lang="en-GB" %)
115 -(% lang="en-US" style="font-family:Calibri,serif" %)Adults
116 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
130 +(% lang="en-US" %)Adults
131 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
117 117  (% class="western" lang="en-GB" %)
118 -(% lang="en-US" style="font-family:Calibri,serif" %)Youth
119 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
133 +(% lang="en-US" %)Youth
134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
120 120  (% class="western" lang="en-GB" %)
121 -(% lang="en-US" style="font-family:Calibri,serif" %)Children
136 +(% lang="en-US" %)Children
122 122  )))
123 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
138 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
124 124  (% class="western" %)
125 125  
126 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
127 -(% class="western" %)
128 -
129 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
130 -(% class="western" %)
131 -
132 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
133 -(% class="western" %)
134 -
135 135  )))
136 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
142 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
137 137  (% class="western" lang="en-GB" style="text-align:center" %)
138 -(% lang="en-US" style="font-family:Calibri,serif" %)**Health status**
144 +(% lang="en-US" %)**Health status**
139 139  )))
140 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
146 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
141 141  (% class="western" lang="en-GB" %)
142 -(% lang="en-US" style="font-family:Calibri,serif" %)Healthy
143 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
148 +(% lang="en-US" %)Healthy
149 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
144 144  (% class="western" lang="en-GB" %)
145 -(% lang="en-US" style="font-family:Calibri,serif" %)Patient
146 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
151 +(% lang="en-US" %)Patient
152 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
147 147  (% class="western" lang="en-GB" %)
148 -(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant
149 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
154 +(% lang="en-US" %)Rehabilitant
155 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
150 150  (% class="western" lang="en-GB" %)
151 -(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor
157 +(% lang="en-US" %)Recovered/Survivor
152 152  )))
153 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
159 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
154 154  (% class="western" %)
155 155  
156 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
157 -(% class="western" %)
158 -
159 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
160 -(% class="western" %)
161 -
162 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
163 -(% class="western" %)
164 -
165 165  )))
166 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
163 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
167 167  (% class="western" lang="en-GB" style="text-align:center" %)
168 -(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability**
165 +(% lang="en-US" %)**A specific disease, disorder or disability**
169 169  )))
170 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
167 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
171 171  (% class="western" lang="en-GB" %)
172 -(% lang="en-US" style="font-family:Calibri,serif" %)ADHD
173 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
169 +(% lang="en-US" %)ADHD
170 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
174 174  (% class="western" lang="en-GB" %)
175 -(% lang="en-US" style="font-family:Calibri,serif" %)Dementia
176 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
172 +(% lang="en-US" %)Dementia
173 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
177 177  (% class="western" lang="en-GB" %)
178 -(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease
179 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
175 +(% lang="en-US" %)Parkinsons’ disease
176 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
180 180  (% class="western" lang="en-GB" %)
181 -(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation
178 +(% lang="en-US" %)Loneliness and Social Isolation
182 182  )))
183 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
184 184  (% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="font-family:Calibri,serif" %)Autism
186 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
182 +(% lang="en-US" %)Autism
183 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
187 187  (% class="western" lang="en-GB" %)
188 -(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome
189 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
185 +(% lang="en-US" %)Down syndrome
186 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
190 190  (% class="western" lang="en-GB" %)
191 -(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability
192 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
188 +(% lang="en-US" %)Physical disability
189 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
193 193  (% class="western" lang="en-GB" %)
194 -(% lang="en-US" style="font-family:Calibri,serif" %)Mental health
191 +(% lang="en-US" %)Mental health
195 195  )))
196 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
193 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
197 197  (% class="western" lang="en-GB" %)
198 -(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease
199 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
195 +(% lang="en-US" %)Cardiovascular disease
196 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
200 200  (% class="western" lang="en-GB" %)
201 -(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF)
202 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
198 +(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
199 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
203 203  (% class="western" lang="en-GB" %)
204 -(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea
205 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
201 +(% lang="en-US" %)Sleep apnea/apnea
202 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
206 206  (% class="western" lang="en-GB" %)
207 -(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment
204 +(% lang="en-US" %)Mild cognitive impairment
208 208  )))
209 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
206 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
210 210  (% class="western" lang="en-GB" %)
211 -(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD)
212 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
208 +(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
209 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
213 213  (% class="western" lang="en-GB" %)
214 -(% lang="en-US" style="font-family:Calibri,serif" %)Language disability
215 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
211 +(% lang="en-US" %)Language disability
212 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
216 216  (% class="western" lang="en-GB" %)
217 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol)
218 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
214 +(% lang="en-US" %)Substance abuse (drugs, alcohol)
215 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
219 219  (% class="western" lang="en-GB" %)
220 -(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis
217 +(% lang="en-US" %)Multiple sclerosis
221 221  )))
222 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
219 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
223 223  (% class="western" lang="en-GB" %)
224 -(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major)
225 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
221 +(% lang="en-US" %)Cognitive disorder (mild, major)
222 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
226 226  (% class="western" lang="en-GB" %)
227 -(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation
228 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
224 +(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
225 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
229 229  (% class="western" lang="en-GB" %)
230 -(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient
227 +(% lang="en-US" %)Trauma patient
231 231  
232 232  (% class="western" lang="en-GB" %)
233 -(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury)
234 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
230 +(% lang="en-US" %)(e.g., a spinal cord injury)
231 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
235 235  (% class="western" lang="en-GB" %)
236 -(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases
233 +(% lang="en-US" %)Neurodegenerative diseases
237 237  )))
238 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
235 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
239 239  (% class="western" %)
240 240  
241 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
242 -(% class="western" %)
243 -
244 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
245 -(% class="western" %)
246 -
247 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
248 -(% class="western" %)
249 -
250 250  )))
251 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
239 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
252 252  (% class="western" lang="en-GB" style="text-align:center" %)
253 -(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service**
241 +(% lang="en-US" %)**Clients of a specific service**
254 254  )))
255 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
243 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
256 256  (% class="western" lang="en-GB" %)
257 -(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare
258 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
245 +(% lang="en-US" %)Child welfare
246 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
259 259  (% class="western" lang="en-GB" %)
260 -(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home
261 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
248 +(% lang="en-US" %)Nursing home
249 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
262 262  (% class="western" lang="en-GB" %)
263 -(% lang="en-US" style="font-family:Calibri,serif" %)Employment service
264 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
251 +(% lang="en-US" %)Employment service
252 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
265 265  (% class="western" %)
266 266  
267 267  )))
268 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
256 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
269 269  (% class="western" lang="en-GB" %)
270 -(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education
271 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
258 +(% lang="en-US" %)Early childhood education
259 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
272 272  (% class="western" lang="en-GB" %)
273 -(% lang="en-US" style="font-family:Calibri,serif" %)Home care
274 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
261 +(% lang="en-US" %)Home care
262 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
275 275  (% class="western" lang="en-GB" %)
276 276  
277 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
265 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
278 278  (% class="western" lang="en-GB" %)
279 279  
280 280  )))
281 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
269 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
282 282  (% class="western" %)
283 283  
284 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
285 -(% class="western" %)
286 -
287 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
288 -(% class="western" %)
289 -
290 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
291 -(% class="western" %)
292 -
293 293  )))
294 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
273 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
295 295  (% class="western" lang="en-GB" style="text-align:center" %)
296 -(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups**
275 +(% lang="en-US" %)**Vulnerable groups**
297 297  )))
298 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
277 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
299 299  (% class="western" lang="en-GB" %)
300 -(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children
301 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
279 +(% lang="en-US" %)Minors/Children
280 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
302 302  (% class="western" lang="en-GB" %)
303 -(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children
304 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
282 +(% lang="en-US" %)Single parents with minor children
283 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
305 305  (% class="western" lang="en-GB" %)
306 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence
307 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
285 +(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
286 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
308 308  (% class="western" lang="en-GB" %)
309 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance users
288 +(% lang="en-US" %)Substance users
310 310  
311 311  (% class="western" lang="en-GB" %)
312 -(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol)
291 +(% lang="en-US" %)(drugs, alcohol)
313 313  )))
314 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
293 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
315 315  (% class="western" lang="en-GB" %)
316 -(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people
317 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
295 +(% lang="en-US" %)Disabled people
296 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
318 318  (% class="western" lang="en-GB" %)
319 -(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings
320 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
298 +(% lang="en-US" %)Victims of trafficking in human beings
299 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
321 321  (% class="western" lang="en-GB" %)
322 -(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants
323 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
301 +(% lang="en-US" %)Ethnic minorities and immigrants
302 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
324 324  (% class="western" lang="en-GB" %)
325 -(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people
304 +(% lang="en-US" %)Isolated people
326 326  )))
327 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
306 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
328 328  (% class="western" lang="en-GB" %)
329 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people
330 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
308 +(% lang="en-US" %)Elderly people
309 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
331 331  (% class="western" lang="en-GB" %)
332 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses
333 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
311 +(% lang="en-US" %)Persons with serious illnesses
312 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
334 334  (% class="western" lang="en-GB" %)
335 -(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people
336 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
314 +(% lang="en-US" %)Homeless people
315 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
337 337  (% class="western" lang="en-GB" %)
338 -(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background
317 +(% lang="en-US" %)Ex-prisoners and people with criminal background
339 339  )))
340 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
319 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)(((
341 341  (% class="western" lang="en-GB" %)
342 -(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women
343 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
321 +(% lang="en-US" %)Pregnant women
322 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
344 344  (% class="western" lang="en-GB" %)
345 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders
346 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
324 +(% lang="en-US" %)Persons with mental disorders
325 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
347 347  (% class="western" lang="en-GB" %)
348 348  
349 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
328 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
350 350  (% class="western" lang="en-GB" %)
351 351  
352 352  )))
353 353  
333 +:
334 +
354 354  (% class="western" lang="en-GB" %)
355 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
336 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
356 356  
357 -
358 358  |**Researcher expertise**|**Brief use case description**
359 359  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
360 360  |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project